chr8-41757620-G-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000289734.13(ANK1):​c.129+416C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.307 in 152,050 control chromosomes in the GnomAD database, including 7,384 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.31 ( 7384 hom., cov: 33)

Consequence

ANK1
ENST00000289734.13 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.19

Publications

8 publications found
Variant links:
Genes affected
ANK1 (HGNC:492): (ankyrin 1) Ankyrins are a family of proteins that link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 1, the prototype of this family, was first discovered in the erythrocytes, but since has also been found in brain and muscles. Mutations in erythrocytic ankyrin 1 have been associated in approximately half of all patients with hereditary spherocytosis. Complex patterns of alternative splicing in the regulatory domain, giving rise to different isoforms of ankyrin 1 have been described. Truncated muscle-specific isoforms of ankyrin 1 resulting from usage of an alternate promoter have also been identified. [provided by RefSeq, Dec 2008]
ANK1 Gene-Disease associations (from GenCC):
  • hereditary spherocytosis
    Inheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE, LIMITED Submitted by: ClinGen, Orphanet
  • hereditary spherocytosis type 1
    Inheritance: AR, AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.334 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000289734.13. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANK1
NM_000037.4
MANE Select
c.129+416C>T
intron
N/ANP_000028.3
ANK1
NM_001142446.2
c.228+416C>T
intron
N/ANP_001135918.1
ANK1
NM_020476.3
c.129+416C>T
intron
N/ANP_065209.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANK1
ENST00000289734.13
TSL:1 MANE Select
c.129+416C>T
intron
N/AENSP00000289734.8
ANK1
ENST00000265709.14
TSL:1
c.228+416C>T
intron
N/AENSP00000265709.8
ANK1
ENST00000347528.8
TSL:1
c.129+416C>T
intron
N/AENSP00000339620.4

Frequencies

GnomAD3 genomes
AF:
0.307
AC:
46699
AN:
151932
Hom.:
7376
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.272
Gnomad AMI
AF:
0.406
Gnomad AMR
AF:
0.259
Gnomad ASJ
AF:
0.434
Gnomad EAS
AF:
0.206
Gnomad SAS
AF:
0.348
Gnomad FIN
AF:
0.430
Gnomad MID
AF:
0.329
Gnomad NFE
AF:
0.317
Gnomad OTH
AF:
0.318
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.307
AC:
46733
AN:
152050
Hom.:
7384
Cov.:
33
AF XY:
0.311
AC XY:
23093
AN XY:
74330
show subpopulations
African (AFR)
AF:
0.271
AC:
11253
AN:
41470
American (AMR)
AF:
0.259
AC:
3965
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.434
AC:
1505
AN:
3470
East Asian (EAS)
AF:
0.206
AC:
1066
AN:
5166
South Asian (SAS)
AF:
0.348
AC:
1676
AN:
4822
European-Finnish (FIN)
AF:
0.430
AC:
4545
AN:
10560
Middle Eastern (MID)
AF:
0.340
AC:
100
AN:
294
European-Non Finnish (NFE)
AF:
0.317
AC:
21574
AN:
67960
Other (OTH)
AF:
0.321
AC:
679
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1656
3312
4967
6623
8279
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
456
912
1368
1824
2280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.317
Hom.:
22553
Bravo
AF:
0.290
Asia WGS
AF:
0.314
AC:
1089
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.092
DANN
Benign
0.75
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7006290; hg19: chr8-41615138; API